Patents by Inventor Tarik REGAD

Tarik REGAD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AGAINST hEPCR
    Publication number: 20220127374
    Abstract: An antibody or antigen-binding fragment that binds human endothelial protein C receptor (hEPCR) and neutralizes, reduces or interferes with at least one activity of hEPCR, in which (a) the antibody or antigen-binding fragment has a heavy chain variable region (HCVR) with at least 80% identity to a sequence selected from SEQ ID NO: 1, 3, 5 and 7, and/or a light chain variable region (LCVR) with at least 80% identity to a sequence selected from SEQ ID NO: 2, 4, 6 and 8, and/or (b) the antibody or antigen-binding fragment has a heavy chain variable region (HCVR) selected from SEQ ID NO: 1, 3, 5 and 7 with 10 or fewer conservative amino acid substitutions and/or a light chain variable region (LCVR) selected from SEQ ID NO: 2, 4, 6 and 8 with 10 or fewer conservative amino acid substitutions, is disclosed.
    Type: Application
    Filed: February 3, 2020
    Publication date: April 28, 2022
    Applicant: NOTTINGHAM TRENT UNIVERSITY
    Inventor: Tarik REGAD